{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-24-000147","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2024-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.603809+00:00","generated_at":"2026-05-31T21:57:08.678510+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"GoodRx enters Sixth Amendment to Credit Agreement, refinances $500M term loan facility","bullets":["New $500M 2024 Term Loan Facility matures July 2029 with SOFR + 3.75% margin, used to repay Existing Term Loans ($167.2M cash added).","Maturity of $88M of $100M revolving credit facility extended to April 2029; remaining $12M terminates July 2025.","Quarterly principal payments of 0.25% of original principal beginning Q2 2024, prepayment premium 1.00% if before Jan 2025.","Financial covenant requires First Lien Net Leverage Ratio not exceeding 8.2x if revolving borrowings exceed threshold."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-24-000147","json":"https://secwatch.observer/filing/0001809519-24-000147.json","markdown":"https://secwatch.observer/filing/0001809519-24-000147.md","text":"https://secwatch.observer/filing/0001809519-24-000147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/0001809519-24-000147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/gdrx-20240710.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:57:08.678510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}